Larry Donald Zimpleman
Analyst · John Nadel with Sterne Agee
Sure, John. This is Larry. Let me make a few comments. And what I would say here is a very general comment before I walk through a little bit of detail with you. What I would is say is that guidance is based on a full year. And I'd say, it would be very important to remember that things that happen over the course of a full year don't happen in 25% increments over each quarter, okay? So for example, a variable investment income, as an example. Last year, that was a little bit front-loaded. This year, we expect it to be a little bit back-loaded. You have seasonality in Specialty Benefits, as we've commented before. The general comment you might see specialty benefits first quarter earnings be 20% of the full year earnings, not 25%. So what I would say is if you sort of take Terry's normalized, the $0.72, you ramp it up to 2% to 3% that you'd expect so based in our assumptions of equity market growth. That gets you very near the $2.95 to $3 level. You then adjust for things like variable investment income, specialty benefits. You adjust for the change in share count. And you are, if you will, well inside our previously communicated guidance. Having said all of that, we obviously don't update that guidance, and it really doesn't take into account, John, at all, the very strong asset accumulation and net cash flow growth that we saw in the first quarter, which obviously hasn't yet fed through to financials because it's just received in the current quarter. And as the market stays steady and that continues to repeat itself in subsequent quarters, that's going to be a very significant tailwind on earnings as we go into the subsequent quarters of 2012. So like always, there's a number of assumptions in there. But the key thing, I would continue to remind everybody is things don't happen in 1/4 increments every year. There's front loads, there's back loads. All that's taken into account when we gave our guidance back in December.
John M. Nadel - Sterne Agee & Leach Inc., Research Division: That's very helpful. I have one separate one, and that is, are you and the Board giving any consideration to changing your approach to setting your buyback authorization? I asked this, Larry, because obviously with your current approach, you were out of the market for the first 2 months of the year. And that clearly has at least, at the margin, a negative impact on your ability to generate EPS and ROE improvement at a somewhat faster pace.